As of October 31, 2019, the largest concentration of Candida auris cases — 427 of 911 confirmed cases — is in New York4, according to an article on the Infection Control Today website.
“Approximately 3 years into the New York outbreak, these pan-resistant isolates still appear to be rare, but their emergence is concerning,” investigators have said.
C. auris cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City.
The investigators recommended that patients on antifungal treatment for C. auris should be monitored closely for clinical improvement, and follow-up cultures should be obtained.
How Retail Design Principles Can Improve Healthcare Wayfinding
Flexible Design Strategies Help OhioHealth Maximize Clinical Space
Midwest Spine And Brain Institute Suffers Data Breach via Third-Party Vendor
What Accessibility in Senior Care Facilities Should Look Like
Corewell Health to Expand Grand Rapids and Troy Hospitals